Cover Image
Market Research Report

Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Published by The Business Research Company Product code 959778
Published Content info 200 Pages
Delivery time: 2-3 business days
Price
Back to Top
Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
Published: September 9, 2020 Content info: 200 Pages
Description

Anti-Hypertensive Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global anti-hypertensive drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the anti-hypertensive drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Anti-Hypertensive Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Therapeutics: Diuretics; Angiotensin Receptor Blockers (ARBs); Angiotensin Converting Enzyme (ACE) Inhibitors; Beta Blockers; Alpha Blockers; Calcium Channel Blockers; Renin Inhibitors; Vasodilators

2) By Disease source: Primary Hypertension; Secondary Hypertension

3) By End users: Hospitals; Clinics; Homecare

Companies Mentioned: Merck & Co.; Astra Zeneca Plc; Daiichi Sankyo Company Limited; Johnson & Johnson Ltd.; Pfizer

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Anti-Hypertensive Drugs Market Characteristics

3. Anti-Hypertensive Drugs Market Size And Growth

  • 3.1. Global Anti-Hypertensive Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Anti-Hypertensive Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Anti-Hypertensive Drugs Market Segmentation

  • 4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Diuretics
    • Angiotensin Receptor Blockers (ARBs)
    • Angiotensin Converting Enzyme (ACE) Inhibitors
    • Beta Blockers
    • Alpha Blockers
    • Calcium Channel Blockers
    • Renin Inhibitors
    • Vasodilators
  • 4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Primary Hypertension
    • Secondary Hypertension
  • 4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospitals
    • Clinics
    • Homecare

5. Anti-Hypertensive Drugs Market Regional And Country Analysis

  • 5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Anti-Hypertensive Drugs Market

  • 6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview
  • 6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Anti-Hypertensive Drugs Market

  • 7.1. China Anti-Hypertensive Drugs Market Overview
  • 7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Anti-Hypertensive Drugs Market

  • 8.1. India Anti-Hypertensive Drugs Market Overview
  • 8.2. India Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Anti-Hypertensive Drugs Market

  • 9.1. Japan Anti-Hypertensive Drugs Market Overview
  • 9.2. Japan Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Anti-Hypertensive Drugs Market

  • 10.1. Australia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Anti-Hypertensive Drugs Market

  • 11.1. Indonesia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Anti-Hypertensive Drugs Market

  • 12.1. South Korea Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Anti-Hypertensive Drugs Market

  • 13.1. Western Europe Anti-Hypertensive Drugs Market Overview
  • 13.2. Western Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Anti-Hypertensive Drugs Market

  • 14.1. UK Anti-Hypertensive Drugs Market Overview
  • 14.2. UK Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Anti-Hypertensive Drugs Market

  • 15.1. Germany Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Anti-Hypertensive Drugs Market

  • 16.4. France Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Anti-Hypertensive Drugs Market

  • 17.1. Eastern Europe Anti-Hypertensive Drugs Market Overview
  • 17.2. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Anti-Hypertensive Drugs Market

  • 18.1. Russia Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Anti-Hypertensive Drugs Market

  • 19.1. North America Anti-Hypertensive Drugs Market Overview
  • 19.2. North America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Anti-Hypertensive Drugs Market

  • 20.1. USA Anti-Hypertensive Drugs Market Overview
  • 20.2. USA Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Anti-Hypertensive Drugs Market

  • 21.1. South America Anti-Hypertensive Drugs Market Overview
  • 21.2. South America Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Anti-Hypertensive Drugs Market

  • 22.1. Brazil Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Anti-Hypertensive Drugs Market

  • 23.1. Middle East Anti-Hypertensive Drugs Market Overview
  • 23.2. Middle East Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Anti-Hypertensive Drugs Market

  • 24.1. Africa Anti-Hypertensive Drugs Market Overview
  • 24.2. Africa Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Anti-Hypertensive Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Anti-Hypertensive Drugs Market Competitive Landscape
  • 25.2. Anti-Hypertensive Drugs Market Company Profiles
    • 25.2.1. Merck & Co. Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Astra Zeneca Plc
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Daiichi Sankyo Company Limited
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Johnson & Johnson Ltd.
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Pfizer, Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Anti-Hypertensive Drugs Market

27. Anti-Hypertensive Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Anti-Hypertensive Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top